Is Anemia a Serious Disease?
What is Anemia?
Anemia is a condition that manifests through a marked reduction in
hemoglobin concentration or the number of RBCs’ (red blood cells) below their
normal levels (WHO, 2020). The appropriate hemoglobin concentration is
paramount to the transfer of oxygen to various body tissues. A reduction in
hemoglobin or RBCs reduces the overall oxygen-carrying capacity of the blood.
The affected patients could experience symptoms including shortness of breath,
dizziness, weakness, and fatigue. The maintenance of appropriate hemoglobin
concentration is highly needed to accomplish the body’s physiological
requirements. Hemoglobin concentration varies in accordance with pregnancy
status, smoking habits, the height of residence, gender, and age. Anemia
usually develops under the influence of the following causes. Although,
numerous other causes of anemia are widely reported in evidence-based clinical
literature.
- Parasitic infections
- HIV (Human Immunodeficiency
Virus)
- Tuberculosis, malaria, and
other infectious diseases
- Hemoglobinopathies
- Vitamin A/B12
deficiency
- Folate/iron deficiency
Approximately 40% of pregnant women and 42% of kids below five years of
age reportedly experience anemia across the globe (WHO, 2020).
Is Anemia a Disease?
Anemia is not regarded as a clinical diagnosis; however, its presence
indicates an underlying disease condition (Turner, et al., 2020). Anemia
symptoms vary following the presence of comorbidities and etiological factors.
Anemia symptoms in some patients occur after a reduction in hemoglobin level
beneath 7 grams per decilitre. The major chunk of RBCs inside the human body is
produced under the influence of EPO (erythropoietin) of the kidney. EPO
production is triggered by tissue hypoxia; however, hemoglobulin concentration
is inversely proportional to the EPO concentration. This reveals that anemic
patients exhibit an increased concentration of EPO along with a reduction in
hemoglobulin level. Suboptimal EPO level elevation is commonly reported in
anemia of chronic disease, thereby leading to a relative EPO deficiency. Any
reduction in hemoglobin levels affirms the development of anemia. The normal
lab ranges of hemoglobin are mentioned below.
- 13.5-18g/dL (males)
- 12-15g/dL (females)
- 11-16g/dL (children)
- Above 10g/dL in pregnant
women
What are the Commonly Reported
Causes/Risk-Factors of Anemia?
Numerous pathophysiological processes and factors contribute to the
development of anemia. Some of the potential causes are listed below (Warner
& Kamran, 2020) (Johnson-Wimbley, 2011) (Miller, 2013).
- The socioeconomic status,
gender, and age of individuals elevate their risk of anemia and related
complications.
- Iron deficiency anemia
develops under the impact of blood loss, reduced iron absorption, or
limited iron intake.
- The absence of breastfeeding
in infants increases their risk of anemia to many folds.
- Parasitic infection also
increases the risk and prevalence of anemia.
- The nutritional deficiencies
based on the limited intake of vegetables and fruits leads to the
development of anemia in various patient scenarios.
- Reduction in the stomach’s
acidic environment interferes with the iron absorption mechanism.
- Reduction in transferrin
levels.
- Blood loss due to accidents,
nosebleed, and blood donation.
- Iron loss based on hemoglobinuria
and intravascular hemolysis in malaria patients
- Chronic physical
exertion.
- Hookworm infection that
usually develops with mild eosinophilia and iron deficiency anemia.
- Iron malabsorption and
malnutrition.
- History of chronic illness
and underdevelopment.
How Could You Investigate Anemia Through
Physical Examination?
The following findings could help you to identify and track the
development of anemia in high-risk individuals.
Skin-Related Findings
The appearance of one or more of the below-mentioned changes will assist
you to clinically correlate the anemia-related developments.
- Pallor
- Abnormal pigmentation
- Icterus
- Spider nevi
- Petechiae
- Purpura
- Angiomas
- Ulcerations
- Palmar erythema
- Coarseness of hair
- Puffy face
- Thinning of the eyebrows’
lateral aspects
- Nail defects
- Unusual venous prominences
over the abdominal wall
Optic Findings
The sclera and conjunctiva (including conjunctival vessels) of the
anemia suspected patients require an assessment to check and/or rule out the
following conditions.
- Pallor
- Icterus
- Splinter hemorrhages
- Petechiae
- Comma signs
- Telangiectasia
Findings Related to Lymph Nodes
Systemic assessment of lymph nodes is paramount to evaluating or ruling
out the development of anemia. The following considerations could help you to
understand the clinical causes of anemia (Walker, et al., 1990).
- A palpable lymph node
enlargement would indicate the development of neoplasia or infection
requiring further investigation.
- The presence of bilateral
edema would indicate the development of hepatic, or renal, or cardiac
diseases requiring clinical correlation.
- The presence of unilateral
edema would raise suspicion for malignancy-related lymphatic
obstruction.
- The presence of splenomegaly
or hepatomegaly would require further investigation to understand the
pathophysiology of the developing anemia.
- The assessment of the
firmness/tenderness of liver, kidneys, and nodules (if present) would also
facilitate the clinical investigation for anemia
- The non-tenderness and
firmness or liver and kidneys could indicate the presence of a chronic
disorder.
- An infection could elevate
the tenderness and softness of different organs.
- Any infection or tumor in
the pelvis and/or rectum could increase the risk of anemia
- The neurological assessment
for anemia could include the systematic evaluation of tendon reflexes,
cranial nerves, vibratory sense, and position.
- The severity and duration of
anemia are directly proportional to the extent of cardiac
enlargement.
- Bacterial endocarditis
manifests through murmurs that prove to be a significant clue for
anemia.
What are the Commonly Reported
Symptoms/Signs of Anemia?
You may experience one or more of the following symptoms and/or signs
related to anemia (Freeman, et al., 2020).
- Fatigue
- Weakness
- Lightheadedness
- Headache
- Pallor
- Jaundice
- Tachycardia
- Palpitations
- Chest pain
- Dyspnea
- Cold distal
extremities
- Claudication
What is the Pathophysiology of Anemia?
Anemia progresses under the influence of one or more of the following
processes (Freeman, et al., 2020).
- The thalassemia/sickle cell
disease variants of beta and alpha chains of RBCs contribute to the
development of anemia.
- Genetic variations in cell
morphology, cell metabolism, and cell membrane also contribute to the
progression of anemia.
- The absence of substrates
including folate, vitamin B12, and iron deteriorates reticulocyte
metabolism, thereby triggering the onset of anemia.
- Radiation exposure,
infections, toxins, and medications potentially deteriorate the function
of bone marrow, thereby disrupting the production of RBCs.
- The development of fibrosis
or neoplasm across bone marrow also contributes to the development of
anemia.
- Kidney diseases potentially
deteriorate the production of erythropoietin that eventually restricts the
formation of proerythroblasts from pluripotent stem cells.
- Acute blood loss and related
anemia trigger the onset of hypertension that prompts stretch receptors to
generate downstream effects through signaling via the vagus and
glossopharyngeal nerves. These processes elevate the secretion of
vasopressin or arginine vasopressin or antidiuretic hormone that reduces
renal perfusion through increased water reabsorption. The subsequent
activation of the renin-angiotensin system results in vascular tone
elevation, aldosterone induction, and intravascular volume
enhancement.
- Acute blood loss anemia
impacts the physiology of the pituitary gland, cerebral cortex, and
medulla in a manner to elevate antidiuretic hormone secretion and
sympathetic tone enhancement. This eventually triggers the brain volume
changes.
- The renal-mediated and
CNS-directed responses to perfusion/volume loss arising from rapid
hemolysis or blood loss attempt to compensate for the acute onset anemia
and related complications.
- 15% of blood volume loss
results in class-I hemorrhage that does not impact vital signs.
- 15-30% of blood volume loss
causes class-II hemorrhage that potentially increases the risk of peripheral
vasoconstriction, blood pressure reduction, and tachycardia. These
outcomes warrant crystalloid-based volume repletion intervention.
- 30-40% of blood volume loss
leads to class-III hemorrhage that triggers shock, tachycardia, and
hypotension. The clinical management of class-III hemorrhage relies on
blood transfusion and crystalloid resuscitation.
- The blood volume loss above
40% triggers class-IV hemorrhage in a manner that compromises the
compensatory mechanism. The clinical management of class-IV hemorrhage is
based on the administration of pressors, crystalloids, and blood products
(i.e. aggressive resuscitation).
What Laboratory Investigations Could You
Deploy to Investigate Anemia?
Anemia assessment relies on the combination of the following
investigations (Freeman, et al., 2020).
- Hemogram, including mean
corpuscular hemoglobin concentration, mean corpuscular hemoglobin, mean
corpuscular volume, hematocrit, and hemoglobin.
- Iron profile based on total
iron-binding content, ferritin, and serum iron.
- Reticulocyte count for the
assessment of bone marrow’s RBC output.
- Serum creatinine for the
assessment of kidney function.
- Peripheral blood smear for
the assessment of RBC morphology.
- Coagulation screen for the
assessment of thrombin time, international normalized ratio/prothrombin
time, and activated partial prothrombin time.
- Liver function test/panel
for the assessment of 5'-nucleotidase, gamma-glutamyl transferase, lactate
dehydrogenase, alkaline phosphatase, albumin, bilirubin, total protein,
transaminases, and calcium.
- Thyroid function panel for
the assessment of thyroid-stimulating hormone and T-4 (thyroxine)
levels.
- Macrocytosis profile to
evaluate the levels of homocysteine, methylmalonic acid, folate, and
vitamin B-12.
- Hemolysis profile for the
assessment of indirect bilirubin, lactate dehydrogenase, and
haptoglobin.
- Hemoglobin electrophoresis
for the assessment of amino acid chains
- Bone marrow assessment
- Abdominal sonogram for the
assessment of spleen/liver size.
How Could You Prevent Anemia?
The assessment and mitigation of anemia’s causative factors are highly
necessary for its prevention and treatment. The below-mentioned strategies
could help you to reduce your risk of anemia (Medicine_Net, 2020) (IOM, 1993)
(DeMaeyer, et al., 1989, p. 38).
- Incorporation of folic acid
and vitamin B12 in the diet
- Restriction in consumption
of coffee and/or tea with meals
- Elevated consumption of
fluids and food items rich in vitamin C (ascorbic acid)
- Elevated consumption of
bread, iron-fortified cereals, beans, lentils, lean red meat, and green
leafy vegetables.
- Increased consumption of
fruit juices
- Increased consumption of
meat
- Administration of iron
supplements to anemic women
- The consumption of the
iron-folate supplement is highly recommended for pregnant women (based on
physician prescription) to reduce their risk of anemia
- The coadministration of iron
supplements is recommended with juice/water/milk at bedtime or between meals.
- Anemia screening for females
is highly recommended within the age range of 15-25 years
- The regular consumption of
the following vegetables and fruits also reduces the risk of anemia
a)
Boiled turnip
b)
Raw tomato
c)
Boiled
spinach
d)
Boiled sweet
potato
e)
Raw sweet
potato
f)
Boiled potato
g)
Raw potato
h)
Boiled
cauliflower
i)
Raw
cauliflower
j)
Boiled
cabbage
k)
Raw cabbage
l)
Fresh mango
m)
Fresh
pineapple
n)
Fresh orange
o)
Fresh lemon
juice
p)
Fresh guava
DeMaeyer,
E. M. et al., 1989. Prevention and Controlling Iron Deficiency Anemia Through
Primary Health Care. In: Geneva: s.n., pp. 1-61.
Freeman,
A. M., Pandya, N. K. & Morando, D. W., 2020. Anemia Screening. Treasure
Island (FL): StatPearls Publishing.
IOM, 1993.
Recommended Guidelines For Preventing And Treating Iron Deficiency Anemia In
Nonpregnant Women Of Childbearing Age. In: Iron Deficiency Anemia:
Recommended Guidelines for the Prevention, Detection, and Management Among
U.S. Children and Women of Childbearing Age. Washington (DC): National
Academies Press.
Johnson-Wimbley,
T. D., 2011. Diagnosis and management of iron deficiency anemia in the 21st
century. Therap Adv Gastroenterol, 4(3), pp. 177-184.
Medicine_Net,
2020. Health Tip: Help Prevent Anemia. [Online]
Available at: https://www.medicinenet.com/a_visual_guide_to_anemia/article.htm
[Accessed 21 05 2020].
Miller, J.
L., 2013. Iron Deficiency Anemia: A Common and Curable Disease. Cold
Spring Harb Perspect Med, 3(7).
Turner,
J., Parsi, M. & Badireddy, M., 2020. Anemia. In: StatPearls. Treasure
Island (FL): StatPearls Publishing.
Walker, H.
K., Hall, W. D. & Hurst, J. W., 1990. Anemia. Boston:
Butterworths.
Warner, M.
J. & Kamran, M. T., 2020. Anemia, Iron Deficiency. In: StatPearls. Treasure
Island (FL): s.n.
WHO, 2020.
Anaemia. [Online]
Available at: https://www.who.int/health-topics/anaemia#tab=tab_1
[Accessed 20 05 2020].